|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,280.00 JPY | +0.87% |
|
+7.81% | +12.58% |
| 02-06 | Japan's Nikkei rallies on earnings in unsteady trade before Sunday election | RE |
| 02-06 | Japanese drugmakers slump after Trump unveils discount drug website | RE |
Chart calendar Chugai Pharmaceutical Co., Ltd.
Upcoming events on Chugai Pharmaceutical Co., Ltd.
| 24/04/2026 | Q1 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 24/04/2026 | Q1 2026 Earnings Call | Add to your calendar Google Apple ICS format |
| 28/06/2026 | For interim dividend | Add to your calendar Google Apple ICS format |
| 24/07/2026 | Q2 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 24/07/2026 | Q2 2026 Earnings Call | Add to your calendar Google Apple ICS format |
| 27/10/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 27/10/2026 | Q3 2026 Earnings Call | Add to your calendar Google Apple ICS format |
| 28/12/2026 | Final dividend | Add to your calendar Google Apple ICS format |
| 03/02/2027 | Q4 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 28/04/2027 | Q1 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 28/07/2027 | Q2 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 21/10/2027 | Q3 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Chugai Pharmaceutical Co., Ltd.
| 29/01/2026 | Q4 2025 Earnings Call |
| 29/01/2026 | Q4 2025 Earnings Release |
| 14/01/2026 | J.P. Morgan Healthcare Conference |
| 28/12/2025 | Final dividend |
| 28/12/2025 | Anniversary bonus dividend |
| 24/10/2025 | Q3 2025 Earnings Call |
| 24/10/2025 | Q3 2025 Earnings Release |
| 24/07/2025 | Q2 2025 Earnings Call |
| 24/07/2025 | Q2 2025 Earnings Release |
| 26/06/2025 | For interim dividend |
| 26/06/2025 | Anniversary bonus dividend |
| 24/04/2025 | Q1 2025 Earnings Call |
| 24/04/2025 | Q1 2025 Earnings Release |
| 27/03/2025 | Annual General Meeting |
| 30/01/2025 | Q4 2024 Earnings Call |
| 30/01/2025 | Q4 2024 Earnings Release |
| 16/12/2024 | R&D Day |
| 13/11/2024 | Analyst Meeting |
| 25/10/2024 | Q3 2024 Earnings Call |
| 25/10/2024 | Q3 2024 Earnings Release |
Past dividends on Chugai Pharmaceutical Co., Ltd.
| 28/12/2025 | Bonus Payment 75 JPY |
| 28/12/2025 | Final Payment 72 JPY |
| 26/06/2025 | Bonus Payment 75 JPY |
| 26/06/2025 | Interim Payment 50 JPY |
| 26/12/2024 | Final Payment 57 JPY |
| 26/06/2024 | Interim Payment 41 JPY |
| 27/12/2023 | Final Payment 40 JPY |
| 28/06/2023 | Interim Payment 40 JPY |
| 28/12/2022 | Final Payment 40 JPY |
| 28/06/2022 | Interim Payment 38 JPY |
| 28/12/2021 | Final Payment 46 JPY |
| 28/06/2021 | Interim Payment 30 JPY |
| 28/12/2020 | Final Payment 30 JPY |
| 28/06/2020 | Interim Payment 75 JPY |
| 26/12/2019 | Bonus Payment 44 JPY |
| 26/12/2019 | Final Payment 48 JPY |
| 25/06/2019 | Interim Payment 48 JPY |
| 25/12/2018 | Final Payment 41 JPY |
| 25/12/2018 | Bonus Payment 14 JPY |
| 26/06/2018 | Interim Payment 31 JPY |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 1 259 946 1 196 601 5.29% | 1 111 367 1 118 401 -0.63% | 1 170 611 1 158 106 1.08% | 1 257 900 1 246 856 0.89% | 1 342 132 | 1 459 763 |
|
EBITDA Million JPY | Released Forecast Spread | 565 376 505 113 11.93% | 470 914 465 355 1.19% | 573 667 576 916 -0.56% | 643 900 634 490 1.48% | 690 421 | 780 108 |
|
EBIT Million JPY | Released Forecast Spread | 533 309 485 993 9.74% | 439 174 436 264 0.67% | 542 002 541 284 0.13% | 598 800 595 154 0.61% | 661 717 | 756 180 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 531 166 495 383 7.22% | 443 821 436 982 1.57% | 543 034 540 412 0.49% | 597 800 595 375 0.41% | 687 509 | 768 472 |
|
Net income Million JPY | Released Forecast Spread | 374 429 351 818 6.43% | 325 472 321 716 1.17% | 387 317 391 777 -1.14% | 434 000 428 090 1.38% | 483 991 | 554 210 |
|
EPS JPY | Released Forecast Spread | 228 214 6.43% | 198 196 1.16% | 235 238 -1.16% | 264 260 1.4% | 294 | 337 |
| Announcement Date | 02/02/23 | 01/02/24 | 30/01/25 | 29/01/26 |
Quarterly results
| Fiscal Period | June | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 S1 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 S1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 273 812 292 342 -6.34% | 236 900 242 461 -2.29% | 315 911 276 349 14.32% | 552 860 500 300 10.51% | 315 700 280 871 12.4% | 302 111 290 332 4.06% | 288 500 261 540 10.31% | 290 004 320 348 -9.47% | 578 463 584 900 -1.1% | 333 200 333 521 -0.1% | 322 082 | 298 000 | 337 833 | 616 000 | 345 267 | 370 933 | 303 000 | 647 000 |
|
EBITDA Million JPY | Released Forecast Spread | 131 116 102 000 28.55% | 107 900 116 900 -7.7% | 166 021 136 600 21.54% | 169 300 119 300 41.91% | 129 842 127 800 1.6% | 144 700 140 100 3.28% | 144 740 168 500 -14.1% | 176 300 186 600 -5.52% | 126 900 | 160 800 | 206 500 | 196 500 | 169 600 | |||||
|
EBIT Million JPY | Released Forecast Spread | 121 576 126 008 -3.52% | 99 900 100 028 -0.13% | 158 321 122 961 28.76% | 258 195 211 100 22.31% | 160 400 129 349 24.01% | 123 402 128 408 -3.9% | 136 700 111 096 23.05% | 136 691 161 432 -15.33% | 273 342 286 550 -4.61% | 156 500 165 181 -5.26% | 159 268 | 147 700 | 155 700 | 310 400 | 168 850 | 198 650 | 153 300 | 337 400 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 122 690 129 117 -4.98% | 99 900 101 600 -1.67% | 158 801 120 150 32.17% | 258 690 211 350 22.4% | 158 800 128 700 23.39% | 124 400 126 850 -1.93% | 135 800 110 833 22.53% | 136 001 165 710 -17.93% | 271 830 286 800 -5.22% | 156 100 204 018 -23.49% | 152 934 | 153 250 | 150 100 | 310 900 | 173 700 | 179 800 | 153 600 | 337 900 |
|
Net income Million JPY | Released Forecast Spread | 91 206 91 800 -0.65% | 74 400 73 914 0.66% | 111 861 90 095 24.16% | 186 262 154 400 20.64% | 109 500 90 664 20.78% | 91 517 99 436 -7.96% | 97 200 84 654 14.82% | 97 155 124 006 -21.65% | 194 389 209 800 -7.35% | 111 200 126 230 -11.91% | 110 406 | 110 767 | 127 300 | 221 900 | 131 850 | 127 900 | 109 400 | 241 400 |
|
EPS JPY | Released Forecast Spread | 55,4 56,5 -1.92% | 45,2 47,5 -4.82% | 68,0 53,0 28.18% | 113 92,9 21.85% | 66,5 60,4 10.17% | 55,7 59,0 -5.65% | 59,1 49,7 18.87% | 59,0 75,8 -22.07% | 118 128 -7.93% | 67,6 73,3 -7.77% | 72,1 | 59,7 | 70,4 | 135 | 71,6 | 95,0 | 66,5 | 147 |
| Announcement Date | 01/02/24 | 24/04/24 | 25/07/24 | 25/07/24 | 25/10/24 | 30/01/25 | 24/04/25 | 24/07/25 | 24/07/25 | 24/10/25 | - | - | - | - | - | - | - | - |
| 17/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 17/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 18/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 18/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 18/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 20/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 22/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
Past sector events for Chugai Pharmaceutical Co., Ltd.
| 13/02/2026 | Q3 2026 Earnings Release | |
| 12/02/2026 | Q3 2026 Earnings Release | |
| 12/02/2026 | Q3 2026 Earnings Release | |
| 12/02/2026 | Q3 2026 Earnings Release | |
| 12/02/2026 | Q3 2026 Earnings Release | |
| 12/02/2026 | Q3 2026 Earnings Release | |
| 12/02/2026 | Q3 2025 Earnings Release | |
| 12/02/2026 | Q3 2025 Earnings Release | |
| 12/02/2026 | Q4 2025 Earnings Release | |
| 12/02/2026 | Q4 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4519 Stock
- Calendar Chugai Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















